# ICON plc HEOR

Source: https://cn.bioecon.ru/companies/icon-plc-heor/
Updated: 2026-08-16

- 国家: Ireland
- 代码: NASDAQ:ICLR

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 员工人数 | 40,100名员工 (2025-12-31) | https://www.biospace.com/press-releases/icon-reports-fourth-quarter-and-full-year-2025-results-and-provides-outcome-of-audit-committee-investigation |
| 营收 | $8,251.3 million (2025-12-31) | https://www.biospace.com/press-releases/icon-reports-fourth-quarter-and-full-year-2025-results-and-provides-outcome-of-audit-committee-investigation |
| 生产基地 | 中央实验室设施位于Farmingdale（美国）、Dublin（爱尔兰）、新加坡和北京（中国） | https://icon.widen.net/s/tgsbtchmjt/icon_central_laboratories-biorepository-statement-02-july-2024, https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-facilities |
| 认证 | CAP（美国病理学家协会）、CLIA（临床实验室改进修正案）、NGSP、ISO 15189及上海市临床检验中心（SCCL）认证/资质 | https://icon.widen.net/s/tgsbtchmjt/icon_central_laboratories-biorepository-statement-02-july-2024, https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-facilities |
| 监管批准 | 在多种全球监管要求下运营；保存记录以供监管机构和客户在审计期间检查 | https://investor.iconplc.com/static-files/dc127d25-0d7c-46b5-8245-2b1c7bd58f57 |
| 产能 | 运营符合 GMP 要求的早期临床生产设施，以及配备综合实验室和药房基础设施的专业临床研究单元 | https://www.iconplc.com/solutions/early-clinical/clinical-research-units, https://www.iconplc.com/solutions/manufacturing-pharmacy-services |

独立来源: biospace.com, investor.iconplc.com

## 技术

- [卫生经济学与结果研究（HEOR）服务](https://cn.bioecon.ru/technology/heor-b2b-services/)